Review the side-effects of Duvelisib as documented in medical literature. The term "side effects" refers to unintended effects that can occur as a result of taking the medication. In majority of the instances these side-effects are mild and easily tolerable, however sometimes they can be more severe and can be detrimental.
If the side effects are not tolerable adjusting the dosage or switching to a different medication can help to manage or overcome side effects. If you have any doubts or questions, we recommend seeking advice from your doctor or pharmacist.
Gastrointestinal: Diarrhea, stomach pain, nausea, vomiting, constipation, mucositis
Nervous system: Headache, fever, abnormal weakness
Respiratory: Cough, difficulty in breathing, sinusitis, pneumonia or lung infection
Lab abnormalities: Abnormal levels of neutrophils, platelets, red blood cells, lymphocytes, liver enzymes, potassium, calcium, and sodium
Others: Muscle pain, weight loss, decreased appetite, rashes, fluid accumulation
• Breastfeeding is not advised during the treatment and for at least one month after the last dose of duvelisib.
• Never suggest duvelisib capsules to another person even if they have the same medical condition and do not use duvelisib for the condition it is not prescribed.
• Do not stop taking duvelisib capsules without the consent of the doctor.
If the side effects are not tolerable adjusting the dosage or switching to a different medication can help to manage or overcome side effects. If you have any doubts or questions, we recommend seeking advice from your doctor or pharmacist.
Gastrointestinal: Diarrhea, stomach pain, nausea, vomiting, constipation, mucositis
Nervous system: Headache, fever, abnormal weakness
Respiratory: Cough, difficulty in breathing, sinusitis, pneumonia or lung infection
Lab abnormalities: Abnormal levels of neutrophils, platelets, red blood cells, lymphocytes, liver enzymes, potassium, calcium, and sodium
Others: Muscle pain, weight loss, decreased appetite, rashes, fluid accumulation
Other Precautions :
• Women of reproductive potential and men with active female partners should use effective contraception during duvelisib treatment and must continue for at least one month after the last dose of duvelisib.• Breastfeeding is not advised during the treatment and for at least one month after the last dose of duvelisib.
• Never suggest duvelisib capsules to another person even if they have the same medical condition and do not use duvelisib for the condition it is not prescribed.
• Do not stop taking duvelisib capsules without the consent of the doctor.
